16 This study concluded that GLP-1 drugs for weight loss were associated with a reduced risk of developing dry AMD at five, seven and 10 years compared to other weight loss drugs
Available from: alzinfo.org How GLP-1s Could Transform Alzheimers Treatment. BrightFocus Foundation
A published case report is underway, though, and we can expect another report from these doctors in a couple of months
2019 Aldous \ Walker helped secure a $37M verdict against Honda over poorly designed seat belt system
This included MACE, cardiovascular mortality, all-cause mortality, myocardial infarction, stroke, hospitalisation for heart failure and adverse effects, including acute pancreatitis, severe hypoglycaemia and gastrointestinal side-effects (Table 1)
However, NICE guideline NG28 specifies continuation criteria: treatment should be reviewed after approximately 6 months and only continued if you've achieved both a reduction in HbA1c of at least 11 mmol/mol (1%) and weight loss of at least 3%